logo
MVM was founded in 1997 and manages four funds totalling more than US$700 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.
Industries:

Investor Types:
Investment Stages:

Location: London, England, United Kingdom